Sermorelin is the primary topic on Retapedia for the
terms listed below. This page distinguishes other meanings and
related entries.
Sermorelin (also called GHRH (1-29), GRF 1-29, Geref, Sermorelin acetate) may refer to:
Primary topic
- Sermorelin — Stimulates the pituitary to release growth hormone and IGF-1 while preserving normal feedback control. FDA-approved for diagnosing and treating GH deficiency; used off-label for anti-aging. Nightly subcutaneous injection.
Also known as
The following names are catalogued aliases for the primary topic:
- GHRH (1-29)
- GRF 1-29
- Geref
- Sermorelin acetate
Related entries on Retapedia
- CJC-1295/Ipamorelin Stack — Boosts growth hormone 3-5x higher than individual peptides. Improves sleep quality, muscle mass, fat loss, and recovery. Minimal side effects.
- CJC-1295 — Increases growth hormone and IGF-1 for 6+ days per injection. Improves body composition, muscle recovery, and fat metabolism. Weekly dosing.
- Growth hormone — A 191-amino-acid peptide hormone secreted by the anterior pituitary that stimulates growth, cell reproduction, and IGF-1 production. Prohibited as a performance enhancer.
External meanings
The term GHRH (1-29) may carry meanings outside this catalogue — for example, as a developmental code shared with an unrelated chemical entity, or as a trademarked product name in a different therapeutic area. Retapedia does not catalogue non-peptide compounds; consult an external reference such as PubChem or Wikidata for broader coverage.
Categories:
Disambiguation pages